BioCurex, Inc.(fka BOCX)

[was Gyro]

U.S. Breast Disease Diagnostic and Therapeutic Devices Market Poised to Grow to over $2.7 Billion by 2012
Sep 11 2007, 3:40 PM EST
News source: Business Wire
http://www.genengnews.com/news/bnitem.aspx?name=22911843

Technology innovations are driving record sales in the breast care market, according to a new Life Science Intelligence (LSI) industry report, which forecasts the U.S. markets for devices used to diagnose and treat breast disease to grow from $1.2 billion in 2006 to $2.7 billion by 2012. The new report, "U.S. Markets for Breast Disease Diagnostic and Therapeutic Technologies," provides a detailed analysis of the patients, procedures, technologies, and companies driving growth and innovation in the breast disease diagnosis and treatment markets. The report segments the market into three primary areas including non-interventional diagnostic technologies, interventional diagnostic technologies, and therapeutic technologies. Several factors driving growth are analyzed in the report including conversion of mammography to digital systems, adoption of local breast irradiation (brachytherapy) for cancer therapy, and broadened adoption of MRI screening procedures to find occult cancers. Future diagnostic innovations, such as development of cost effective screening ultrasound technologies, could add entirely new, and significant, growth opportunities. Many established technologies, such as percutaneous breast biopsy, have been successful, but they have not yet achieved their full market potential. The report analyzes the drivers, limiters, and opportunities available to both established and emerging medical device companies participating in the breast care market.

The report contains 240 pages, 98 exhibits, and coverage of key competitors including Aloka, Aurora, Bard, Cardinal, Confirma, Cytyc, Esaote, Ethicon Endo-Surgery, Fuji, GE, Hitachi, Hologic, Inrad, Intact, InterV, Philips, Rubicor, Sanarus, Scimedix, Sectra, SenoRx, Sentenelle, Siemens, Site Select, Sonosite, Suros Surgical Systems, and Toshiba among others.

Additional details can be found at http://lifescienceintelligence.com/07-US-Market-Breast-Disease.php or by calling 714 847 3540.

About Life Science Intelligence

Life Science Intelligence (LSI) delivers high quality market data and information to medical technology executives, entrepreneurs and investors. LSI produces the Emerging Medical Technology Database and provides custom research services including market assessments and physician surveys. In addition, the company partners with top tier information and consulting companies to distribute other high end information products. Learn more at www.lifescienceintelligence.com